The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma

Clinical Infectious Diseases

Volumn 51, Issue 5, 2010, Pages 571-574

  Haug, Sara ^a,b   Lakew, Takele ^d   Habtemariam, Gabremaskal ^d   Alemayehu, Wondu ^d   Cevallos, Vicky ^a   Zhou, Zhaoxia ^a,b   House, Jenafir ^a   Ray, Kathryn ^a   Porco, Travis ^a,b,c   Rutar, Tina ^b   Keenan, Jeremy ^a,b   Lietman, Thomas M ^a,b,c   Gaynor, Bruce D ^a,b,e  

^a FI Proctor Foundation   (United States)

^b Department of Ophthalmology ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ORBIS INTERNATIONAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHIOPIA; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STREPTOCOCCUS PNEUMONIAE; TRACHOMA;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; ETHIOPIA; FEMALE; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TRACHOMA;

EID: 77955811174     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/655697     Document Type: Article

References (16)

1. Resnikoff S, Pascolini D, Etyáale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-851.
2. Kumaresan J. Can blinding trachoma be eliminated by 20/20? Eye 2005; 19:1067-1073.
3. Wright HR, Turner A, Taylor HR. Trachoma. Lancet 2008; 371:1945-1954.
4. Mariotti SP. New steps toward eliminating blinding trachoma. N Engl J Med 2004; 351:2004-2007.
5. Report of the eighth meeting of the WHO alliance for the global elimination of blinding trachoma. World Health Organization Web site. http://www.who.int/blindness/publications/GET-8-Report.pdf. Published 2004. Accessed 14 July 2010.
6. Thylefors B, Dawson CR, Jones BR,West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. BullWorld Health Organ 1987; 65:477-483.
7. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999; 5:572-576.
8. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 2004; 292:721-725.
9. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366:1296-1300. (Pubitemid 41416585)
10. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997; 24:356-362.
11. Fry AM, Jha HC, Lietman TM, et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002; 35:395-402.
12. Gaynor BD, Chidambaram JD, Cevallos V, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol 2005; 89:1097-1099.
13. Melese M, Alemayehu W, Lakew T, et al. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA 2008; 299:778-784.
14. O'Brien KL, Bronsdon MA, Dagan R, et al. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 2001; 39:1021-1024.
15. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Wayne, PA: CLSI; 2009. CLSI document M44-S3.
16. Waites K, Johnson C, Gray B, Edwards K, Crain M, Benjamin W Jr. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol 2000; 38:1731-1734.